AU2002255196A1 - Rapidly dispersing solid oral compositions - Google Patents

Rapidly dispersing solid oral compositions

Info

Publication number
AU2002255196A1
AU2002255196A1 AU2002255196A AU2002255196A AU2002255196A1 AU 2002255196 A1 AU2002255196 A1 AU 2002255196A1 AU 2002255196 A AU2002255196 A AU 2002255196A AU 2002255196 A AU2002255196 A AU 2002255196A AU 2002255196 A1 AU2002255196 A1 AU 2002255196A1
Authority
AU
Australia
Prior art keywords
solid oral
oral compositions
rapidly dispersing
dispersing solid
rapidly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002255196A
Inventor
Abhijit Mukund Deshmukh
Vipin Tatyasaheb Dhanorkar
Muralikrishna Divi
Mailatur Sivaraman Mohan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Publication of AU2002255196A1 publication Critical patent/AU2002255196A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002255196A 2002-04-18 2002-04-18 Rapidly dispersing solid oral compositions Abandoned AU2002255196A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/001272 WO2003086361A1 (en) 2002-04-18 2002-04-18 Rapidly dispersing solid oral compositions

Publications (1)

Publication Number Publication Date
AU2002255196A1 true AU2002255196A1 (en) 2003-10-27

Family

ID=29227356

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002255196A Abandoned AU2002255196A1 (en) 2002-04-18 2002-04-18 Rapidly dispersing solid oral compositions

Country Status (2)

Country Link
AU (1) AU2002255196A1 (en)
WO (1) WO2003086361A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21303A (en) * 2002-10-18 2004-04-30 Krka, Tovarna Zdravil, D.D.,, Novo Mesto Pharmaceutical formulation of olanzapine
WO2005077341A1 (en) * 2004-01-19 2005-08-25 Ranbaxy Laboratories Limited Orally disintegrating pharmaceutical compositions of ondansetron
CN105801686B (en) 2004-07-19 2020-04-07 比奥孔有限公司 Insulin-oligomer conjugates, formulations and uses thereof
EP1681048A1 (en) * 2005-01-14 2006-07-19 Krka Tovarna Zdravil, D.D., Novo Mesto Orally disintegrating composition of olanzapine or donepezil
CZ297214B6 (en) * 2005-02-02 2006-10-11 Zentiva, A. S. Pharmaceutical composition containing olanzapine as active component and process for its preparation
WO2006087629A2 (en) * 2005-02-21 2006-08-24 Aurobindo Pharma Limited Rapidly disintegrating composition of olanzapine
BRPI0502736A (en) * 2005-07-05 2007-02-27 Biolab Sanus Farmaceutica Ltda oral formulations of masked residual flavor ondansetron
US20080004260A1 (en) * 2006-06-29 2008-01-03 Transcept Pharmaceuticals, Inc. Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions
WO2008032767A1 (en) * 2006-09-14 2008-03-20 Astellas Pharma Inc. Orally disintegrating tablet and process for production thereof
US9241908B2 (en) 2007-10-16 2016-01-26 Biocon Limited Orally administrable solid pharmaceutical composition and a process thereof
WO2010065930A1 (en) 2008-12-04 2010-06-10 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating or preventing narcotic withdrawal symptoms
TR200903293A1 (en) 2009-04-28 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral disintegrating olanzapine tablet.
CA2953546A1 (en) 2014-06-24 2015-12-30 Taho Pharmaceuticals Fast acting orally disintegrating film
CN107625740A (en) * 2016-07-18 2018-01-26 北京科信必成医药科技发展有限公司 A kind of Ondansetron is anhydrous to swallow particle
CN110881555A (en) * 2019-11-07 2020-03-17 哈尔滨梵境园生物科技有限公司 Dispersible candy tablet with dual-effect of lowering blood pressure
GB202212379D0 (en) * 2022-08-25 2022-10-12 GlaxoSmithKline Consumer Healthcare UK IP Ltd Novel toothpaste tablet composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
CR5278A (en) * 1995-03-24 1996-07-04 Lilly Co Eli ORAL FORMULATION OF 2-METHYL-THENO-BENZODIACEPINE
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
WO2000057857A1 (en) * 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration

Also Published As

Publication number Publication date
WO2003086361A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
AUPS146402A0 (en) Nanofiller compositions
AU2002311922A1 (en) Oral care compositions
AU2003295693A1 (en) Improved sunscreen compositions
AU2003279340A1 (en) Shampoo compositions
AU2003225444A1 (en) Oral suspension formulation
AU2003285288A1 (en) Composition
AU2003256805A1 (en) Compounds compositions and methods
AU2003234909A1 (en) Powder composition
AU2002255196A1 (en) Rapidly dispersing solid oral compositions
AU2002950744A0 (en) Composition
AU2003235708A1 (en) Polytartrate composition
GB0126244D0 (en) Oral compositions
AU2003302305A1 (en) Benzoquinolizine-2-carboxylic acid-containing compositions
AU2003252683A1 (en) Composition for oral use
AU2002358764A1 (en) Antiperspirant compositions
AU2003269904A1 (en) Antigen-polymer compositions
AU2003208411A1 (en) Anti-glycolytic composition
AU2002321808A1 (en) Dental compositions
AU2001270235A1 (en) Oral compositions
AU2003301902A1 (en) Cosmetic compositions
AU2001290669A1 (en) Oral compositions
AU2003208841A1 (en) Gasolinen compositions
AU2003216382A1 (en) Idothyronine compositions
AU2003268772A1 (en) Oil-barrier composition
AU2003218497A1 (en) FACTORVIIa COMPOSITIONS

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase